Data processing: measuring – calibrating – or testing – Measurement system – Remote supervisory monitoring
Reexamination Certificate
2006-08-22
2006-08-22
Hoff, Marc S. (Department: 2857)
Data processing: measuring, calibrating, or testing
Measurement system
Remote supervisory monitoring
C702S188000, C702S081000, C702S083000, C370S908000, C700S009000, C700S213000, C700S214000, C700S215000, C588S249000, C588S253000, C707S793000, C707S793000, C707S793000
Reexamination Certificate
active
07096161
ABSTRACT:
A pharmaceutical hazardous waste identification and management system integrates disparate information regarding pharmaceuticals to provide an indication of which pharmaceuticals are hazardous wastes as defined by respective national, international and state regulations and/or which are hazardous materials as defined by the US OSHA regulations. A subset of this information offers a global repository with respect to the occurrence, concentrations, and ecotoxicologic data of pharmaceuticals based on peer reviewed data provided by environmental toxicologists and related scientists.
REFERENCES:
patent: 5532928 (1996-07-01), Stanczyk et al.
patent: 5712990 (1998-01-01), Henderson
patent: 5845255 (1998-12-01), Mayaud
patent: 6097995 (2000-08-01), Tipton et al.
patent: 6397115 (2002-05-01), Basden
patent: 6542902 (2003-04-01), Dulong et al.
patent: 6618852 (2003-09-01), van Eikeren et al.
patent: 6633795 (2003-10-01), Suzuki et al.
patent: 2003/0004965 (2003-01-01), Farmer et al.
patent: 2003/0131011 (2003-07-01), Haunschild et al.
patent: 2003/0139640 (2003-07-01), Whittacre et al.
APM ‘Asen Production Management for the Pharmaceutical Industry’, Sep. 2001, pp. 1-21.
Holly V. Campbell, “Pharmaceuticals in the Environment: Regulatory and Nonregulatory Approaches,” ERL News & Analysis, Copyright 2002 Environmental Law Institute®, Washington, D.C., Oct. 2002 (pp. 11200-11211).
“Report to Congress: Evaluating the Consensus Best Practices Developed through the Howard Hughes Medical Institute's Collaborative Hazardous Waste Management Demonstration Project and the Need for Regulatory Changes to Carry Out Project Recommendations,” United States Environmental Protection Agency, Office of Solid Waste and Emergency Response, EPA530-R-02-008, Mar. 2002 ( 2 pgs.).
Memorandum of Understanding Between the U.S. Department of Health and Human Service and the U.S. Environmental Protection Agency, Sep. 30, 2002 (pp. 1-5).
Beyond RCRA: Prospects for Waste and Materials Management in the Year 2002, White Paper, Jun. 2002 (pp. 1-18).
“A Guide on Hazardous Waste Management for Florida's Pharmacies,” University of Florida—Florida C nt r For Solid and Hazardous Waste Management (pp. 1-21).
Pharmecology Associates, LLC brochure (1 sheet).
The Pharmecology Wizard brochure (1 sheet).
Charlotte A. Smith, R.Ph, M.S., “Managing Pharmaceutical Waste—What Pharmacists Should Know,” Journal of the Pharmacy Society of Wisconsin, Nov/Dec 2002, (pp. 17-22).
Bruce R. Siecker, Ph.D., R.Ph., and Charlotte A. Smith, R.Ph., M.S., “The Long Arm of the Law in Distribution Regulatory Overview of the Drug Distribution Industry,” HealthCare Distributor, Oct/Nov 2002, (pp. 62-63).
“Improper Discard of toxic Drugs Hurts Environment, Leads to Fines,” Reprinted from American Journal of Health-System Pharmacy, vol. 58, Sep. 1, 2001 (pp. 1576-1578).
Charlotte A. Smith, “Bad Medicine—Managing Drug Waste Liabilities,” Reprinted from Health Facilities Management, Jan. 2001, vol. 14, No. 1 (2 pgs.).
Charlotte A. Smith, “Rationale for Inclusion of Criteria for Proper Disposal of Monograph Pharmaceutical Preparations Based on the Resource Conservation and Recovery Act,” Pharmacopeial Forum, vol. 25, No. 3, May-Jun. 1999 (pp. 8309-8312).
“Discard Woes—Hurdles Mount for Disposing of Unwanted Rx Drugs,” Reprinted from Drug Topics Magazine, May 18, 1998 (1 pg.).
Claudia Morain, “EPA Still Regulates Disposal of Many Drug Materials Found in pharmacies,” Reprint from Pharmacy Practice News, Jan. 1996 (1 pg.).
Charlotte A. Smith, R.Ph., M.S., “Reverse Distributors Should Establish Operational Standards,” Reprinted From Wholesale Drugs, Aug. 1996 (1 pg.).
“Your Risks in Handling Outdated and Unusable Drugs—A guide to JCAHO and Regulatory Standards,” Capital Returns, Inc. 1998 (pp. 1-36).
Charlotte A. Smith, R.Ph., M.S., North Memorial Health Care, “Pharmaceutical Waste Management R view,” Dec. 20, 2001 (pp. 1-18).
Charlotte A. Smith, R.Ph., M.S., “Pharmaceutical Waste Management Review—Aug. 5, 2002,” UWHealth, Jul., 2002 (pp. 1-138).
Charlotte A. Smith, R.Ph., M.S., “Hazardous Waste Disposal Analysis—Oct. 29, 2002,”U.S. Oncology, Inc., Jul., 2002 (pp. 1-127).
Christian G. Daughton and Thomas A. Ternes, “Pharmaceuticals and Personal Care Products in the Environment: Agents of Subtle Chang ?,” Environmental Health Perspective, vol. 107, Supplement 6, Dec. 1999 (pp. 907-938).
Dana Kolpin, Edward T. Furlong, Michael T. Meyer, E. Michael Thurman, Steven D. Zaugg, Larry B. Barber, Herbert T. Buxton, “Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance,” Environmental Science & Technology, vol. 36, No. 6, 2002 (pp. 1202-1211).
O.A.H. Jones, N. Voulvoudis and J.N. Lester, “Human Pharmaceuticals in the Aquatic Environment a Review,” Environmental Technology, vol. 22 (pp. 1383-1394).
F.M. Christensen, “Pharmaceuticals in the Environment—A Human Risk?,” Regulatory Toxicology and Pharmacology 28, 1998 (pp. 212-221).
Emerging Issues Conference Jun. 7-8, 2000, Minneapolis, Minnesota, http://toxics.usgs.gov/meetings
gwa-ei.html (1 pg.).
“Pharmaceuticals and Personal Care Products (PPCPs) as Environmental Pollutants,” EPA, http://www.epa.gov
erlesd1/chemistry/pharma/index.htm (pp. 1-3).
“National Exposure Research Laboratory Environmental Sciences,” EPA, http://www.epa.gov
erlesd1/chemistry/pharma/kummer/default.htm (9 pgs.).
“Water and Health Program—Environmental Science and Engineering,” Harvard School of Public Health, http://www.hsph.harvard.edu/water/ (1 pg.).
Britt E. Erickson, “Analyzing the Ignored Environmental Contaminants,” Environmental Science and Technology, Apr. 1, 2002, (pp. 141A-145A).
Ovid: Bibliographic Records Sep. 30, 2002-Oct. 1, 2002 (3 pgs.).
“Widespread Pollutants with Endocrine-disrupting Effects,” Our Stolen Future: Book Basics: Chemicals Implicated, http://www.ourstolenfuture.org/Basics/chemlist.htm, (pp. 1-8).
2002 Endocrine Disruptors Conferences, American Water Works Association, http://www.awwa.org/02endocrine (pp. 1-2).
“Exposure to Hazardous Drugs: Time to Reevaluate your Program,” American Journal of Health-System Pharmacy, vol. 56, Jul. 15, 1999 (pp. 1402, 1427-1432).
Melissa A. McDiarmid, MD, MPH, Hubert T. Gurley, MD, and David Arrington, MS “Pharmaceuticals as Hospital hazards: Managing the Risks,” Journal of Occupational Medicine, vol. 33, No. 2, Feb. 1991 (pp. 155-158).
“Cytotoxic Agents: Mechanisms of Action and Potential Toxicity,” ONS Symposia, (pp. 5-8).
Aspen Production Management for the Pharmaceutical Industry, APM, White Paper, Sep. 2001, pp. 1-21.
page print from website http://chppm-www.apgea.army.mil/hmwp/Factsheets/MIDI-INFO.h. . . dated Dec. 12, 2005; Military Item Disposal Instructions and Military Environmental Information Source (MIDI/MEIS) CD-ROM, December 2000”.
McCauley James R.
Smith Charlotte A.
Desta Elias
Foley & Lardner LLP
Hoff Marc S.
PharmEcology Associates, LLC
LandOfFree
Pharmaceutical hazardous waste identification and management... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical hazardous waste identification and management..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical hazardous waste identification and management... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693263